Pilulka Lékárny a.s. Cash Flow Statement

Financials in millions CZK. Fiscal year is January - December.

Millions CZK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-38.87	-125.74	-174.94	-64.94	-25.5
Depreciation & Amortization	14.96	19.65	22.83	17.85	22.31
Other Amortization	21.68	47	53.62	35.33	12.64
Loss (Gain) From Sale of Assets	3.12	3.41	0.02	0.1	0.05
Other Operating Activities	-9.35	5.66	0.02	-5.53	9.01
Change in Accounts Receivable	17.97	93.26	23.94	-14.09	-28.25
Change in Inventory	-7.77	39.7	91.04	-31.96	-64.63
Change in Accounts Payable	-22.17	-127.93	-50.8	25.08	99.03
Operating Cash Flow	-20.43	-44.99	-34.29	-38.15	24.67
Capital Expenditures	-	-20.06	-35.63	-76.77	-82.13
Sale of Property, Plant & Equipment	2.8	8.56	0.02	0.1	0.05
Investing Cash Flow	2.8	-11.5	-35.61	-76.68	-82.08
Long-Term Debt Issued	16.04	64.15	-	4.66	-
Long-Term Debt Repaid	-	-	-1.1	-	-3.26
Net Debt Issued (Repaid)	16.04	64.15	-1.1	4.66	-3.26
Issuance of Common Stock	-	-	67.39	0.02	-
Financing Cash Flow	16.04	64.15	66.29	4.68	-3.26
Foreign Exchange Rate Adjustments	-1	-1.08	0.45	0.45	0.5
Net Cash Flow	-2.58	6.58	-3.17	-109.69	-60.17
Free Cash Flow	-20.43	-65.05	-69.92	-114.92	-57.46
Free Cash Flow Margin	-2.33%	-4.99%	-3.28%	-4.70%	-2.41%
Free Cash Flow Per Share	-7.55	-24.03	-25.83	-45.59	-
Cash Interest Paid	16.98	12.33	10.48	4.76	0.06
Levered Free Cash Flow	18.69	61.26	6.15	-90.97	-
Unlevered Free Cash Flow	29.3	68.97	12.7	-87.99	-
Change in Working Capital	-11.97	5.02	64.17	-20.96	6.15